Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Aoyama

Showing results (41-50 of 421) with videos related to

Pageof 43
Sort By:
Annals of Surgical Oncology|December 7, 2011
Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomyToru Aoyama, Takaki Yoshikawa, Tsutomu Hayashi, et al.
Journal of Cancer Research and Therapeutics|December 13, 2022
Outcomes of feeding jejunostomy after pancreaticoduodenectomy: A single-center experienceNaoto Yamamoto, Toru Aoyama, Masaaki Murakawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[Randomized phase II trial to compare S-1 and S-1/PSK for advanced or recurrent gastric cancer-lessons from the results]Takaki Yoshikawa, Akira Tsuburaya, Zenichiro Saze, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 19, 2012
[Neoadjuvant chemotherapy for gastric cancer--evidence from the world and future strategy in Japan]Takaki Yoshikawa, Toru Aoyama, Tsutomu Hayashi, et al.
American Journal of Cancer Research|September 2, 2015
Organic cation transporter 2 for predicting cisplatin-based neoadjuvant chemotherapy response in gastric cancerAyano Naka, Risa Takeda, Michiko Shintani, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 18, 2017
Does a laparoscopic approach attenuate the body weight loss and lean body mass loss observed in open distal gastrectomy for gastric cancer? a single-institution exploratory analysis of the JCOG 0912 phase III trialToru Aoyama, Tsutomu Sato, Tsutomu Hayashi, et al.
Biochemical and Biophysical Research Communications|April 7, 2009
gamma-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient miceToru Aoyama, Kyosuke Takeshita, Ryosuke Kikuchi, et al.
Atherosclerosis|January 9, 2013
Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery diseaseHideki Ishii, Toru Aoyama, Hiroshi Takahashi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2012
Nonlinear measures of heart rate variability and mortality risk in hemodialysis patientsMari Suzuki, Takahashi Hiroshi, Toru Aoyama, et al.
In Vivo (Athens, Greece)|September 13, 2022
Clinical Significance of Mean Corpuscular Volume in Patients With Locally Advanced Esophageal Squamous Cell CarcinomaHayato Watanabe, Kazuki Kano, Itaru Hashimoto, et al.
Pageof 43

Showing results (41-50 of 421) with videos related to

Sort By:
Pageof 43
Annals of Surgical Oncology|December 7, 2011
Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomyToru Aoyama, Takaki Yoshikawa, Tsutomu Hayashi, et al.
Journal of Cancer Research and Therapeutics|December 13, 2022
Outcomes of feeding jejunostomy after pancreaticoduodenectomy: A single-center experienceNaoto Yamamoto, Toru Aoyama, Masaaki Murakawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[Randomized phase II trial to compare S-1 and S-1/PSK for advanced or recurrent gastric cancer-lessons from the results]Takaki Yoshikawa, Akira Tsuburaya, Zenichiro Saze, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 19, 2012
[Neoadjuvant chemotherapy for gastric cancer--evidence from the world and future strategy in Japan]Takaki Yoshikawa, Toru Aoyama, Tsutomu Hayashi, et al.
American Journal of Cancer Research|September 2, 2015
Organic cation transporter 2 for predicting cisplatin-based neoadjuvant chemotherapy response in gastric cancerAyano Naka, Risa Takeda, Michiko Shintani, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 18, 2017
Does a laparoscopic approach attenuate the body weight loss and lean body mass loss observed in open distal gastrectomy for gastric cancer? a single-institution exploratory analysis of the JCOG 0912 phase III trialToru Aoyama, Tsutomu Sato, Tsutomu Hayashi, et al.
Biochemical and Biophysical Research Communications|April 7, 2009
gamma-Secretase inhibitor reduces diet-induced atherosclerosis in apolipoprotein E-deficient miceToru Aoyama, Kyosuke Takeshita, Ryosuke Kikuchi, et al.
Atherosclerosis|January 9, 2013
Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery diseaseHideki Ishii, Toru Aoyama, Hiroshi Takahashi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 23, 2012
Nonlinear measures of heart rate variability and mortality risk in hemodialysis patientsMari Suzuki, Takahashi Hiroshi, Toru Aoyama, et al.
In Vivo (Athens, Greece)|September 13, 2022
Clinical Significance of Mean Corpuscular Volume in Patients With Locally Advanced Esophageal Squamous Cell CarcinomaHayato Watanabe, Kazuki Kano, Itaru Hashimoto, et al.
Pageof 43